U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07589686) titled 'A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight' on May 11.
Brief Summary: The main purpose of this study is to evaluate the safety and efficacy of the co-administration of petrelintide and enicepatide compared with placebo, petrelintide monotherapy, and enicepatide monotherapy in participants with obesity or overweight with at least one weight-related comorbidity.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Obesity or Overweight
Intervention:
DRUG: Petrelintide
Petrelintide will be administered subcutaneously to participants once weekly
COMBINATION_PR...